Official facilitator of


Uterine cancer chemotherapy in the Assuta - innovation and safety

uterine cancer chemotherapy Chemotherapy uses anticancer drugs designed to slow or stop the growth of rapidly dividing cancer cells in the body. It is recommended:

  1. As a primary treatment to destroy abnormal cells.
  2. Before another method of therapy to reduce the tumor volume.
  3. After surgery to remove the remaining cancer segments.
  4. To facilitate the manifestation of advanced cancer.

If you are considering treatment options abroad, our company can help with the organization of chemotherapy uterine cancer in one of the best private medical centers in Israel - Assuta. We have experience in the medical tourism market for over 10 years, is carried out on a contractual basis with the cooperation of family clinics in Israel, both private and public.

In a short time you will arrange for high-quality medical assistance, bringing the possibility of different medical institutions. The range of services is quite wide: the selection of the doctor, the hospital, the organization and coordination of the process of diagnostics and treatment services at all stages of searching and booking of accommodation, transport services, recreation programs and so forth.

As part of the treatment at Assuta cost of services will be similar to rates of the International Clinic of tourism, but the list of non-medical services - more extensive. You can write to us through the inquiry form and call the designated phone.

Team and individual approach to chemotherapy uterine cancer

Himioterapevt works closely with the rest of the team, discussing the treatment regimen and taking decisions based on the individual patient.

Assuta Doctors use several treatment protocols for each patient seeking to find the most suitable drug, or a combination thereof. For this purpose, employ highly accurate diagnostic tests that help to avoid unnecessary toxicity.

If women receive chemotherapy for uterine cancer oncologist carefully coordinated dosage and schedule controls the effectiveness of the course, respectively changes the treatment plan if necessary. In some cases, the complex attracts other methods - targeted therapy, surgery, radiation.

Molecular profiling of tumors during chemotherapy uterine cancer

The main goal of oncologists - to develop a personalized treatment plan. In order to identify the most suitable means of cytotoxic drugs and targeted therapy, is used molecular profiling of tumors. This test allows you to avoid unnecessary toxicity. Basic diagnostic tasks:

  1. Identify the molecular composition of the tumor.
  2. To choose the most effective treatment on an individual basis, minimizing the consequences of trial and error.
  3. Detect potentially beneficial treatment options, which may not have been considered in the original plan.

How it works?

Each individual has a cancer cell composition of genes and proteins. Molecular tests deepen the diagnosis, help in the staging and treatment of cancer on an individual basis. The sample was checked for the presence of various enzymes, proteins, and genes to determine which methods may be most effective. The data is then compared with the results of thousands of clinical trials. Thus, an individual treatment plan is developed.

Molecular profiling recommend that patients:

  1. With large tumors.
  2. With a highly aggressive cancer that does not respond to standard treatment.
  3. With rare tumor types.

chemotherapy drugs for uterine cancer are tested on a sample in order to identify the most productive, avoiding unnecessary toxicity to the body. Determined the best scheme for a particular type of disease.

chemotherapy drugs for uterine cancer

The types of chemotherapy drugs and combinations thereof, are selected depending on the type of cancer.

endometrial carcinoma

The most common cytostatics used in the treatment of carcinoma, are:

  • doxorubicin (adriamycin)
  • cisplatin (Platinol rr)
  • carboplatin (Paraplatin, Paraplatin rr)
  • ifosfamide
  • paclitaxel (taxol)
  • docetaxel (Taxotere)

Most often used the following scheme of chemotherapy:

  • cisplatin and doxorubicin
  • paclitaxel and doxorubicin
  • carboplatin and docetaxel
  • carboplatin and paclitaxel
  • cisplatin, paclitaxel and doxorubicin.

Carcinosarcoma may be treated with ifosfamide and cisplatin with or without paclitaxel.

uterine sarcoma

The most common chemotherapeutic agents used for the treatment of sarcoma of the uterus:

  • doxorubicin
  • ifosfamide
  • cisplatin
  • paclitaxel
  • docetaxel
  • gemcitabine (Gemzar)

In most cases, these schemes are applied cytostatics:

  • cisplatin and doxorubicin
  • Doxorubicin and ifosfamide
  • docetaxel and gemcitabine

Managing side effects of chemotherapy for uterine cancer

Despite the fact that the treatment of uterine cancer is directed at the abnormal cells, it can cause damage to healthy and cause unwanted effects. A team of doctors at Assuta, which works with the patient, provides a variety of integrative services to help prevent or manage adverse events. Prior to initiation of treatment may be prescribed certain medications that will make the symptoms more bearable.

Many of the side effects go away after treatment ends. It is important to remember that much of it is well controlled with medication.

The main side effects are described below.

risk of infection

While chemotherapy drugs act on cancer cells in the body, they also temporarily reduce the number of white blood cells. This increases the chance of infection.

Before each course of treatment blood test in order to verify that the parameters have returned to normal. Sometimes treatment is delayed if leukocyte count remains low.


When the number of red blood cells is low, the patient feels fatigue and shortness of breath. This condition is called anemia. To eliminate it is used a blood transfusion.

Bruising and bleeding

Chemotherapy can reduce the number of platelets in the blood of cancer of the uterus, the cells that help the blood to clot. If you experience any unexplained bruising or bleeding, such as from the nose, bleeding gums, skin rash, it is important to seek medical advice immediately.

Nausea and vomiting

Some cytostatics provoke similar symptoms. To prevent them used anti-emetics.


During this period, the patient is important to save power. The energy level can be increased by combining moderate physical activity (short walk) from the rest.

poor appetite

During chemotherapy, uterine cancer women generally lose their appetite. It is recommended to eat frequent small meals. There are a significant number of ready-to-use additives, some of which are available by prescription.

Inflammation in the mouth

Certain chemotherapy drugs cause inflammation in the oral cavity. The nurse will give specific recommendations for care.


This problem is easily controlled with medication. You should inform your doctor if it is severe. It should drink 2-3 liters of fluid a day to make up for lost volume.

Hair loss

The doctor informs the patient at Assuta, if received chemotherapy will cause hair loss. But not all drugs used to treat cancer of the uterus, there is a similar side effect. hair growth, even if they have started to drop, resume after chemotherapy uterine cancer.

peripheral neuropathy

Certain cytotoxic agents may have effects on the nerves, causing numbness or tingling. A few months after the treatment ends, the problem goes away, usually slow, sometimes it becomes permanent.

allergic reactions

Taxol is able to provoke an allergic reaction. To reduce the chance that this will happen, prescribe steroids before and after treatment. Symptoms may include skin rashes and itching; high temperature; chills; dizziness; headache; shortness of breath.

The risk of blood clots

Oncology increases the likelihood of thrombus formation and reception of chemotherapy may increase this risk. It is important to seek medical attention if symptoms such as pain, redness and swelling in the leg, shortness of breath and chest pain. In this situation, effective blood thinners.


By submitting this form you agree to the privacy policy


No comments yet

new comment


definitely (will not be published)